RFG Bristol Wealth Advisors LLC Purchases New Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

RFG Bristol Wealth Advisors LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 552 shares of the healthcare conglomerate's stock, valued at approximately $279,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. Meeder Advisory Services Inc. raised its stake in UnitedHealth Group by 4.1% during the 4th quarter. Meeder Advisory Services Inc. now owns 17,092 shares of the healthcare conglomerate's stock valued at $8,646,000 after purchasing an additional 668 shares during the last quarter. OV Management LLC raised its position in shares of UnitedHealth Group by 11.1% during the fourth quarter. OV Management LLC now owns 3,151 shares of the healthcare conglomerate's stock valued at $1,594,000 after buying an additional 314 shares during the last quarter. Trexquant Investment LP acquired a new stake in UnitedHealth Group during the fourth quarter worth about $11,141,000. May Hill Capital LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at approximately $609,000. Finally, Headlands Technologies LLC grew its holdings in shares of UnitedHealth Group by 295.4% during the 4th quarter. Headlands Technologies LLC now owns 8,785 shares of the healthcare conglomerate's stock worth $4,444,000 after purchasing an additional 6,563 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 3.4 %

Shares of UnitedHealth Group stock traded up $17.67 during trading hours on Thursday, hitting $540.87. The company's stock had a trading volume of 6,454,806 shares, compared to its average volume of 4,243,146. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market capitalization of $494.74 billion, a PE ratio of 34.89, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The stock has a 50 day moving average of $509.39 and a 200 day moving average of $542.82.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 earnings per share. The business's revenue was up 6.8% on a year-over-year basis. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group's payout ratio is presently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the business's stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.33% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Stephens raised their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a research report on Thursday, December 5th. Truist Financial dropped their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Wells Fargo & Company lowered their price objective on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 28th. KeyCorp reiterated an "overweight" rating and issued a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Oppenheimer boosted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research note on Friday, December 6th. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.